Doctors issue 'life-threatening' warning over 'King Kong' of weight-loss drugs

Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection f

Unapproved weight-loss drug retatrutide widely available online, creating challenges for clinicians

Non-FDA approved retatrutide is readily available to US consumers from multiple sources, leaving many clinicians grappling with how to manag

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

Experts say results from trial of new triple hormone drug for type 2 diabetes are striking but further tests needed

Eli Lilly’s Michael Kopach says retatrutide leads in obesity treatment and CMC innovation

The pharma company’s latest peptide is so effective, it’s raising eyebrows among medical professionals.

ClinicalTrials.gov

Lilly posted its program for retatrutide in early June, but unlike postings for other drugs, it contains no information about the disease co

Survodutide weight-loss drug may reduce harmful fat while preserving muscle